The dual role of OTUD3 in cancer: mechanisms and therapeutic implications
Jialin Zhang, Lu Lu, Wenchang Xu, Na Zhou, Yongfeng Song · 2025
Read The dual role of OTUD3 in cancer: mechanisms and therapeutic implications by Jialin Zhang, Lu Lu, Wenchang Xu, Na Zhou, Yongfeng Song (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12837120.txt.
Description
Jialin Zhang and co-authors review in 2025 a molecular editor that plays hero in some cancers and villain in others. OTUD3 is an enzyme that strips ubiquitin tags off proteins, sparing them from destruction. Which proteins it spares depends on the tissue, so its net effect flips: it stabilizes famous tumor suppressors in some cancers and shields growth drivers and immune cloaks in others.
The review maps its substrate list, spanning guardians of the genome, heat shock managers, and the PD-L1 immune checkpoint. Beyond tumors, the enzyme touches inflammation, antiviral defense, and metabolic balance. Drug hunters have early candidates, including repurposed medicines and a purpose built blocker, with the best promise in combinations alongside immunotherapy. The same duality that makes OTUD3 exciting makes it risky to drug blindly. The authors call for mapping its networks tissue by tissue before clinical bets are placed.
Catalog record
| CREATOR | Jialin Zhang, Lu Lu, Wenchang Xu, Na Zhou, Yongfeng Song |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |